Cannabis and cannabinoids for medicinal purposes: Reviewing the evidence
This project will review the evidence for the medicinal use of cannabis and cannabinoid products for a number of key medical conditions.
Project Status:
Current
Treatment and Intervention
Update of Fetal Alcohol Spectrum Disorders in Australia: Monograph of the InterGovernmental Committee on Drugs Working Party on Fetal Alcohol Spectrum Disorders
The monograph is an outcome of the Intergovernmental Committee on Drugs (IGCD) Fetal Alcohol Spectrum Disorder (FASD) Working Party.
Project Status:
Completed
Cannabis attitudes and knowledge among GPs
Australian surveys of those with cannabis use disorder (CUD) reveal that general medical practitioners (GPs) are the preferred source of treatment as they are seen as trust worthy and confidential.
Project Status:
Completed
Review of adolescent substance use and responses in the WHO Western Pacific Region
Substance use amongst adolescents (those in the age group of 10-19) is an important public health issue in many countries of the region.
Project Status:
Completed
A randomised controlled study of health intervention "SNAP" in Northern Territory prisons
The Northern Territory prison population comprises 92% Indigenous Australians and 88% smokers. The NT prison-smoking ban creates a population-wide abstinence. We aim to extend this period of abstinence into the community.
Rationale
Project Status:
Current
An evaluation of the New South Wales Involuntary Drug and Alcohol Treatment (IDAT) Program
The IDAT Program, established under the Drug and Alcohol Treatment Act 2007 of New South Wales, aims to “provide short-term care, with an involuntary supervised withdrawal component, to protect the health and safety of people with severe substance dependence who have experienced, or are at risk o
Project Status:
Current
Randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence
This randomised double-blind placebo-controlled study, led by St Vincent's Hospital Sydney, aims to examine the safety and efficacy of lisdexamfetamine in the treatment of adults with severe methamphetamine (MA) dependence.
Project Status:
Current
Treatment services specifications for the NGO drug and alcohol specialist sector in NSW
NADA, under funding provided by the NSW Ministry for Health, is conducting a project to develop a set of treatment service specifications for the NSW specialist NGO drug and alcohol sector.
Project Status:
Completed
Integrated management pathways for alcohol and drug clients into treatment (IMPACT)
This innovative, integrated care project was implemented in the South Eastern Sydney Local Health District to improve integration of services provided to those who are frequent attenders to the Emergency Department and have drug and alcohol use disorders.
Project Status:
Current
An RCT of cannabinoid replacement therapy (Sativex®) for the management of treatment-resistant cannabis dependent patients
This project will conduct the first-ever outpatient RCT to test the efficacy, safety and cost-effectiveness of the pharmaceutical cannabinoid nabiximols (Sativex®) for treating cannabis dependence.
Project Status:
Current